Variant report
Variant | esv3334386 |
---|---|
Chromosome Location | chr6:81179933-81183031 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr6:81182250-81182270 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr6:81181062-81181267 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | POLR2A | chr6:81181047-81181136 | ProgFib | skin: | n/a | n/a |
4 | POLR2A | chr6:81181150-81181155 | ProgFib | skin: | n/a | n/a |
5 | STAT3 | chr6:81182697-81182789 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ELOVL4-3 | chr6:81179788-81180145 | NONHSAT113735 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000219361 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542221112 | chr6:81179951-81179952 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs546180402 | chr6:81180030-81180031 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs560025426 | chr6:81180088-81180089 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs144164600 | chr6:81180100-81180101 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs545238743 | chr6:81180135-81180136 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs72898054 | chr6:81180154-81180155 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs73471500 | chr6:81180164-81180165 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs146509688 | chr6:81180172-81180173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116249675 | chr6:81180190-81180191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140818415 | chr6:81180230-81180231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191245476 | chr6:81180250-81180251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1361553 | chr6:81180257-81180258 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs143002182 | chr6:81180288-81180289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528659510 | chr6:81180293-81180294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117635121 | chr6:81180401-81180402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114531942 | chr6:81180411-81180412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182355944 | chr6:81180430-81180431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs199505232 | chr6:81180445-81180446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188600113 | chr6:81180448-81180449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75024173 | chr6:81180449-81180450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552686503 | chr6:81180453-81180454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73471501 | chr6:81180489-81180490 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs115537942 | chr6:81180502-81180503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114327168 | chr6:81180525-81180526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75004711 | chr6:81180535-81180536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544372653 | chr6:81180565-81180566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561460889 | chr6:81180566-81180567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565401699 | chr6:81180569-81180570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs59085242 | chr6:81180573-81180574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs386703081 | chr6:81180613-81180614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73748616 | chr6:81180614-81180615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs193265703 | chr6:81180620-81180621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532500710 | chr6:81180653-81180654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551708523 | chr6:81180735-81180736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532562090 | chr6:81180846-81180847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373834312 | chr6:81180847-81180848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4299784 | chr6:81180934-81180935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140236857 | chr6:81180985-81180986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550964297 | chr6:81181012-81181013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185043291 | chr6:81181061-81181062 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs190332969 | chr6:81181151-81181152 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs370559663 | chr6:81181169-81181170 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs192288387 | chr6:81181178-81181179 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs184115144 | chr6:81181188-81181189 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs552987783 | chr6:81181277-81181278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566142749 | chr6:81181316-81181317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538214156 | chr6:81181326-81181327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562855245 | chr6:81181344-81181345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373457715 | chr6:81181353-81181354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558845699 | chr6:81181357-81181358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:81167600-81181400 | Weak transcription | Ovary | ovary |
2 | chr6:81167600-81184800 | Weak transcription | Pancreas | Pancrea |
3 | chr6:81168200-81187000 | Weak transcription | Rectal Smooth Muscle | rectum |
4 | chr6:81170800-81187200 | Weak transcription | HSMM | muscle |
5 | chr6:81175600-81180000 | Weak transcription | Fetal Lung | lung |
6 | chr6:81178600-81187000 | Weak transcription | Fetal Intestine Small | intestine |
7 | chr6:81179800-81180000 | Enhancers | Right Ventricle | heart |
8 | chr6:81179800-81180000 | Enhancers | NHDF-Ad | bronchial |
9 | chr6:81179800-81180200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr6:81179800-81180200 | Enhancers | Brain Substantia Nigra | brain |
11 | chr6:81179800-81180200 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr6:81179800-81180200 | Enhancers | Psoas Muscle | Psoas |
13 | chr6:81180000-81180200 | Enhancers | Fetal Lung | lung |
14 | chr6:81180000-81185000 | Weak transcription | NHDF-Ad | bronchial |
15 | chr6:81181000-81182800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr6:81182800-81189800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |